【Abstract】 Objective To discuss the therapeutic effect of transcatheter hepatic arterial chemoemb-olization(TACE) combined with 125I radioactive particles implantation for the treatment of middle-advanced hepatic carcinoma. Methods Eighty-nine cases of hepatic carcinoma were collected from May 2011 to May 2012 and retrospectively analyzed. Of 89 cases, 45 patients were underwent TACE alone (group A), 44 were treated with TACE combined with 125I radioactive particles implantation (group B) under the computer-assisted three-dimensional treatment planning system (TPS). Efficacy evaluation was performed in two months, four months after operation by CT scan. The survival status was recorded in the fourth and ninth months after treatment. Efficacy evaluation and survival status were compared between two groups by chi-square test (P<0.05). Results The OR (CR+PR) were 24.44% (11/45), 17.78% (8/45) in group A, and 54.55% (24/44), 47.73% (21/44) in group B respectively at two months and four months after operation. There were significant differences between two groups (P<0.05). The survival rate at six, nine months in group A (62.22%, 42.22%) were significantly lower than those in group B (90.91%,72.73%),P<0.05. Conclusion TACE combined with 125I radioactive particles implantation is an effective method for the treatment of middle-advanced hepatic carcinoma, which would also improved survival rate.